FeesSafety
Pluang+

Schwab's SCHX ETF costs $60 less annually than SPY on $100K but switching may trigger costly taxes.

Market News
03 Nov 2026, 02:33 WIB
24/7 Wall Street
View Source
Neutral
Schwab's SCHX ETF costs $60 less annually than SPY on $100K but switching may trigger costly taxes.

The Schwab U.S. Large-Cap ETF (SCHX) charges a lower fee of 0.03% compared to SPY's 0.09%, saving about $60 annually on a $100,000 investment. Both ETFs cover large U.S. companies but track different indexes, so returns differ slightly. However, switching from SPY to SCHX in a taxable account can trigger capital gains taxes that may outweigh fee savings. SCHX is best suited for new investments, retirement accounts, or lots with losses, where tax impact is minimized.

The Schwab U.S. Large-Cap ETF fee comparison with SPY provides context for readers. For those following the U.S. stock market, Pluang data shows that on Nov 03, 2026, 85 of 150 priced US stocks rose while 64 fell. Notable movers include XPEV at USD 9.63 with a 6.53% gain and AMD at USD 472.30 with a 6.47% loss, as of 07:01 WIB.

More News

Global Indemnity delays Q3 earnings call to January, introducing new CEO Jessica Buss.

Global Indemnity delays Q3 earnings call to January, introducing new CEO Jessica Buss.

Global Indemnity Group will postpone its third quarter 2026 earnings call originally scheduled for November 4 to January, when new CEO Jessica Buss will present her vision and priorities for the company. The company will still release its Q3 results ...

Market News
Neutral
55 minutes ago
Lorraine Ben joins Syntax Defence as Canada boosts defence spending over $500B in a decade

Lorraine Ben joins Syntax Defence as Canada boosts defence spending over $500B in a decade

Lorraine Ben, former CEO of Lockheed Martin Canada, has joined Syntax Defence to provide expert counsel amid Canada's commitment to invest over half a trillion dollars in defence over the next decade. This includes $180 billion in procurement opportu...

Market News
Bullish
1 hour ago
Dianthus Therapeutics grants stock options to new hires under Nasdaq inducement rule

Dianthus Therapeutics grants stock options to new hires under Nasdaq inducement rule

Dianthus Therapeutics, a clinical-stage biotech company, granted stock options to three new non-executive employees as inducements for joining the company. The options cover 26,000 shares at an exercise price of $82.25, vesting over four years. This ...

Company Fundamentals
Neutral
2 hours ago
Zentalis grants 136,000 stock options to new hires under Nasdaq inducement rule

Zentalis grants 136,000 stock options to new hires under Nasdaq inducement rule

Zentalis Pharmaceuticals awarded 136,000 non-qualified stock options to four newly hired employees as an inducement to join the company, under Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $1.85, matching the stock's closing p...

Company Fundamentals
Neutral
2 hours ago
Federal Home Loan Bank of Atlanta elects new directors and appoints 2027 Chair and Vice Chair.

Federal Home Loan Bank of Atlanta elects new directors and appoints 2027 Chair and Vice Chair.

The Federal Home Loan Bank of Atlanta announced the election of three new member directors and the re-election of one independent director to its board for 2026. Suzanne DeFerie was named Chair and Kathy McKinney Vice Chair for 2027, ensuring experie...

Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App